Product NDC: | 14783-093 |
Proprietary Name: | Supremacie |
Non Proprietary Name: | Ensulizole, Homosalate, Octinoxate, Oxybenzone, and Titanium Dioxide |
Active Ingredient(s): | .00075; .001; .00375; .00225; .000585 g/5mL; g/5mL; g/5mL; g/5mL; g/5mL & nbsp; Ensulizole, Homosalate, Octinoxate, Oxybenzone, and Titanium Dioxide |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 14783-093 |
Labeler Name: | Ventura International LTD |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part352 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20100104 |
Package NDC: | 14783-093-94 |
Package Description: | 1 TUBE in 1 BOX (14783-093-94) > 5 mL in 1 TUBE (14783-093-93) |
NDC Code | 14783-093-94 |
Proprietary Name | Supremacie |
Package Description | 1 TUBE in 1 BOX (14783-093-94) > 5 mL in 1 TUBE (14783-093-93) |
Product NDC | 14783-093 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Ensulizole, Homosalate, Octinoxate, Oxybenzone, and Titanium Dioxide |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 20100104 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | Ventura International LTD |
Substance Name | ENSULIZOLE; HOMOSALATE; OCTINOXATE; OXYBENZONE; TITANIUM DIOXIDE |
Strength Number | .00075; .001; .00375; .00225; .000585 |
Strength Unit | g/5mL; g/5mL; g/5mL; g/5mL; g/5mL |
Pharmaceutical Classes |